Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT of Nebilet in Blood Pressure Control in Patients with Hypertension
TCTR20240903005Recruiting
- Sponsor
- Menarini Group
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nebivolol in hypertension (HTN), sponsored by Menarini Group. Started Dec 2024; status: recruiting.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20240903005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240903005.